[{"id":"94873d44-89bb-4c48-9b4e-dbd9362136c3","acronym":"","url":"https://clinicaltrials.gov/study/NCT01156870","created_at":"2023-08-14T12:10:40.318Z","updated_at":"2024-07-02T16:37:22.653Z","phase":"Phase 1","brief_title":"First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor","source_id_and_acronym":"NCT01156870","lead_sponsor":"Sanofi","biomarkers":" CA6","pipe":"","alterations":" ","tags":["CA6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SAR566658"],"overall_status":"Completed","enrollment":" Enrollment 114","initiation":"Initiation: 09/08/2010","start_date":" 09/08/2010","primary_txt":" Primary completion: 04/07/2017","primary_completion_date":" 04/07/2017","study_txt":" Completion: 04/07/2017","study_completion_date":" 04/07/2017","last_update_posted":"2017-05-10"}]